A randomized controlled trial of tea tree oil (5%) body wash versus standard body wash to prevent colonization with methicillin-resistant Staphylococcus aureus (MRSA) in critically ill adults: Research protocol

BMC Infectious Diseases

Volumn 8, Issue , 2008, Pages 161-

  Thompson, Gillian ^a   Blackwood, Bronagh ^b   McMullan, Ronan ^a   Alderdice, Fiona A ^b   Trinder, T John ^c   Lavery, Gavin G ^a   McAuley, Danny F ^a,b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c ULSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FUSIDIC ACID; LINEZOLID; METICILLIN; RIFAMPICIN; SOAP; STEROID; TEA TREE OIL;

ADULT; APACHE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DRUG EFFICACY; ENDEMIC DISEASE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; MULTICENTER STUDY; NOSE SMEAR; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 58149347352     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-8-161     Document Type: Article

References (31)

1. Gemmell CG Edwards DI Fraise AP Gould FK Ridgeway GL Warren RE: Joint Working Party of the British Society for Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 2006, 57:589-608. 10.1093/jac/dkl017 16507559
2. Coello R Jiminez J Garcia M Arroyo P Minguez D Fernandez C Cruzet F Gaspar C: Prospective study of infection, colonization and infection with methicillin-resistant Staphylococcus aureus in an outbreak affecting 900 patients. Eur J Clin Infect Dis 1994, 13:74-81. 10.1007/ BF02026130
3. Theaker C Ormonde-Walshe S Azadian B Soni N: MRSA in the critically ill. J Hosp Infect 2001, 48:98-102. 10.1053/jhin.2001.0960 11428875
4. Merrer J Santoli F Appere de Vecchi C Tran B de Jonghe B Outin H: Colonisation pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000, 21:718-723. 10.1086/501721 11089656
5. Cosgrove SE Sakoulas G Perencevitch EN Schwaber MJ Karchmer AW Carmeli Y: Comparison of mortality associated with methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteraemia: A meta-analysis. Clin Infect Dis 2003, 36:53-59. 10.1086/345476 12491202
6. The management and control of hospital-acquired infections in acute NHS trusts in England Report by the Comptroller and Auditor General
7. Chaix C Durand-Zaleski I Alberti C Brun-Buisson C: Control of endemic methicillin-resistant Staphylococcus aureus: A cost-benefit analysis in an intensive care unit. JAMA 1999, 282:1745-1751. 10.1001/ jama.282.18.1745 10568647
8. Welch KE Goff DA Fish DN Sierawski SJ Paladino JA: A multicenter economic analysis of bacteremia caused by methicillin-resistant Staphylococcus aureus [abstract] Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 26-29, 1999 Washington, DC: American Society for Microbiology 1999 742
9. Abramson MA Sexton DJ: Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: At what costs? Infect Control Hosp Epidemiol 1999, 20:408-411. 10.1086/ 501641 10395142
10. Harbarth S Rutschmann O Sudre P Pittet D: Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998, 158:182-189. 10.1001/ archinte.158.2.182 9448557
11. Kim T Oh PI Simor AE: The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001, 22:99-104. 10.1086/501871 11232886
12. Barakate MS Yang Y-X Foo SH Vickery AM Sharp CA Fowler LD Harris JP West RH Macleod C Benn RA: An epidemiological survey of methicillin-resistant Staphylococcus aureus in a tertiary referral hospital. J Hosp Infect 2000, 44:19-26. 10.1053/jhin.1999.0635 10633049
13. Hoefnagels-Schuermans A Borremans A Peetermans W Vav Lierde S Reybrouck G van Eldere J: Origin and transmission of methicillin-resistant Staphylococcus aureus in an endemic situation: Differences between geriatric and intensive care patients. J Hosp Infect 1997, 36:209-222. 10.1016/S0195-6701(97)90196-1 9253702
14. Messager S Hammer KA Carson CF Riley TV: Assessment of the antibacterial activity of tea tree oil using the European EN1276 and EN12054 standard suspension tests. J Hosp Infect 2005, 59:113-125. 10.1016/ j.jhin.2004.07.015 15620445
15. Carson CF Mee BJ Riley TV: Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrob Agents Chemother 2002, 46:1914-1920. 127210 12019108 10.1128/ AAC.46.6.1914-1920.2002
16. Dryden MS Dailly S Crouch M: A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization. J Hosp Infect 2004, 56:283-286. 10.1016/ j.jhin.2004.01.008 15066738
17. Caelli M Porteus J Carson CF Heller R Riley TJ: Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000, 46:236-237. 11073734
18. Messager S Hammer KA Carson CF Riley TV: Effectiveness of hand-cleansing formulations containing tea tree oil assessed ex vivo on human skin and in vivo with volunteers using European standard EN 1499. J Hosp Infect 2005, 59:220-228. 10.1016/j.jhin.2004.06.032 15694979
19. The Hypothermia after Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. NEJM 2002, 346:549-556. 10.1056/NEJMoa012689 11856793
20. The SAFE study investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. NEJM 2004, 350:2247-2256. 10.1056/NEJMoa040232 15163774
21. Harvey S Harrison DA Singer M Ashcroft J Jones CM Elbourne D Brampton W Williams D Young D Rowan K: On behalf of the PAC-Man study collaboration Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): A randomised controlled trial. Lancet 2005, 366:472-477. 10.1016/ S0140-6736(05)67061-4 16084255
22. Hammer KA Carson CF Riley TV Nielsen JB: A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food Chem Toxicol 2006, 44:616-625. 10.1016/j.fct.2005.09.001 16243420
23. Carson CF Riley TV Cookson BD: Efficacy and safety of tea tree oil as a topical antimicrobial agent. J Hosp Infect 1998, 40:175-178. 10.1016/ S0195-6701(98)90135-9 9830588
24. Dziekan G Hahn A Thune K Schwarzer G Schafer K Daschner FD Grundmann H: Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study. J Hosp Infect 2000, 46:263-270. 10.1053/jhin.2000.0846 11170757
25. Graffunder EM Venezia RA: Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus infection including previous use of antimicrobials. J Antimicrob Chemother 2002, 49:999-1005. 10.1093/ jac/dkf009 12039892
26. Pujol M Pena C Pallares R Ayats J Ariza J Gudiol F: Risk factors for nosocomial bacteraemia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994, 13:96-102. 10.1007/ BF02026134 8168571
27. Asensio A Guerrero A Quereda C Lizan M Martinez-Ferrer M: Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol 1996, 17:20-28. 8789683
28. Law MR Gill ON: Hospital acquired infection with methicillin-resistant and methicillin-sensitive staphylococci. Epidemiol Infect 1988, 101:623-629. 3215291
29. Ibelings MM Bruining HA: Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Eur J Surg 1998, 164:411-418. 10.1080/110241598750004210 9696441
30. Guide to the Methods of Technology Appraisal (reference N0515) London: NICE 2004
31. Netten A Curtis L: Unit Costs of Health and Social Care, Personal Social Services Research Unit (PSSRU). University of Kent at Canterbury 2006